State of the art in benefit-risk analysis: medicines

J. Luteijn^*, B. White, H. Gunnlaugsdottir, F. Holm, N. Kalogeras, O. Leino, S. Magnusson, G.J. Odekerken-Schröder, M. Pohjola, M.J. Tijhuis, J. Tuomisto, O. Ueland, P.A. McCarron, H. Verhagen

^*Corresponding author for this work